Has Marjorie Yang, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,470 in general payments to Marjorie Yang, MD across 299 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Marjorie Yang, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Marjorie Yang, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Marjorie Yang, MD

Dermatology · Pleasant Prairie, WINPI 1891990974

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 90.0% of the total across 299 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AbbVie at 30.9% of the total.

$3,470in general payments, 2019–2025

Across 299 payments — averaging $11.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$1K
Johnson & Johnson$604
Sun Pharmaceutical Industries Inc.$574
Novartis$252
Sanofi$222
Dermavant Sciences, Inc.$156
plus $588 from 16 others

What the payments were for

Food & beverage$3,12490%
Education$34610%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	112	$1,073
Johnson & Johnson	30	$604
Sun Pharmaceutical Industries Inc.	89	$574
Novartis	18	$252
Sanofi	13	$222
Dermavant Sciences, Inc.	5	$156
UCB, Inc.	6	$127
Merz North America, Inc.	1	$103
Sanofi-aventis U.S. LLC	1	$80
Mayne Pharma Commercial LLC	7	$41
EPI Health, LLC	3	$39
LEO Pharma Inc.	2	$32
VYNE Pharmaceuticals Inc.	1	$27
Lilly USA, LLC	2	$26
Regeneron Healthcare Solutions, Inc.	1	$26
Biofrontera Inc.	2	$23
E.r. Squibb & Sons, L.L.C.	1	$16
Galderma Laboratories, L.p.	1	$14
Sandoz	1	$13
Arcutis Biotherapeutics, Inc.	1	$13
Musculoskeletal Transplant Foundation Inc.	1	$7
Organon	1	$0

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

VTAMA$125

How this compares

$3,470 in reported general payments places this provider in the 80th percentile of 260 dermatology providers in Wisconsin.

See all dermatology providers in Wisconsin →

Medicare billing

Part B allowed, 2024

$190,862

Medicare patients

492

Services billed

2,977

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Skyrizi PenRisankizumab-Rzaa	11	$217,258
OtezlaApremilast	22	$93,573
Taltz AutoinjectorIxekizumab	11	$74,359
Clobetasol Propionate	85	$2,925
Ketoconazole	191	$2,773
Doxycycline Monohydrate	108	$2,157
Halobetasol Propionate	34	$2,001
Betamethasone Dipropionate	74	$2,001
Fluorouracil	28	$1,616
Imiquimod	42	$1,340
Metronidazole	30	$1,268
Triamcinolone Acetonide	65	$1,130
Mupirocin	117	$1,093
Mometasone Furoate	64	$1,079
Clindamycin Phosphate	18	$419

Paid to pharmacies, not to this prescriber.

Other dermatology in Pleasant Prairie

Platina GershtensonPleasant Prairie$6K
David NelsenJanesville$1.1M
Gabriela MaloneyOconomowoc$725K
Kenneth GordonWauwatosa$577K
Ashley DietrichMilwaukee$466K
Martin OkunFort Atkinson$232K
Betsy WernliManitowoc$177K
Daniel OpelSheboygan$118K
Stephen LewellisPlover$73K
Patrick SafoStevens Point$53K

See the full list for Wisconsin →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →